AllianceBernstein
FENC icon

AllianceBernstein’s Fennec Pharmaceuticals FENC Stock Holding History

AllianceBernstein’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.4K Hold
10,310
– – ﹤0.01% 3175
2025
Q4 		$79.4K Hold
10,310
– – ﹤0.01% 3187
2025
Q3 		$96.5K Buy
+10,310
New +$89.3K ﹤0.01% 3183

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

AllianceBernstein's FENC Position: Q1 2026 in Review

AllianceBernstein held its Fennec Pharmaceuticals (FENC) position steady in Q1 2026 at 10,310 shares worth $79.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3175.

AllianceBernstein first reported a position in FENC in Q3 2025 and has held it in 3 quarters since. The position peaked at $96.5K in Q3 2025. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • AllianceBernstein held 10,310 shares of Fennec Pharmaceuticals worth $79.4K as of Q1 2026.
  • AllianceBernstein left its Fennec Pharmaceuticals share count unchanged in Q1 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #3175 holding.
  • AllianceBernstein first reported a position in Fennec Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • AllianceBernstein's Fennec Pharmaceuticals position peaked at $96.5K in Q3 2025.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.